Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Tracon Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −9 vs. Q3 2021
- Shares held
- 9.16M
- −928.2K (−9.2%) vs. Q3 2021
- Total value
- $25.4M
- −$13.7M (−35.0%) vs. Q3 2021
- New holders
- 3
- 8 more added
- Sold out
- 12
- 9 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 29 | $1.39M |
| Q4 2023 | 24 | $903.4K |
| Q3 2023 | 21 | $1.66M |
| Q2 2023 | 27 | $2.90M |
| Q1 2023 | 32 | $18.8M |
| Q4 2022 | 32 | $14.6M |
| Q3 2022 | 33 | $16.5M |
| Q2 2022 | 31 | $19.7M |
| Q1 2022 | 35 | $24.0M |
| Q4 2021 | 35 | $25.4M |
| Q3 2021 | 45 | $39.6M |
| Q2 2021 | 44 | $58.5M |
| Q1 2021 | 42 | $72.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Tracon Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCI Wealth Advisors, Inc. | 300 | $1.00K | 0.00% | +100+50.0% | Added |
| Truvestments Capital LLC | 318 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 786 | $2.00K | 0.00% | +47+6.4% | Added |
| Wells Fargo & Company | 1,330 | $3.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,405 | $4.00K | 0.00% | −23,299−94.3% | Reduced |
| Simplex Trading, LLC | 8,134 | $22.0K | 0.00% | +8,134 | New |
| Coastal Bridge Advisors, LLC | 11,900 | $32.0K | 0.01% | +11,900 | New |
| We Are One Seven, LLC | 11,780 | $33.0K | 0.00% | 00.0% | Unchanged |
| Hoylecohen, LLC | 13,000 | $36.0K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 16,200 | $44.0K | 0.00% | +15,000+1,250.0% | Added |
| Northern Trust Corp | 17,337 | $48.0K | 0.00% | 00.0% | Unchanged |
| X-Square Capital, LLC | 17,973 | $50.0K | 0.03% | 00.0% | Unchanged |
| CSS LLC | 18,761 | $52.0K | 0.00% | +3,861+25.9% | Added |
| Dimensional Fund Advisors LP | 19,563 | $54.0K | 0.00% | −3,032−13.4% | Reduced |
| Acadian Asset Management LLC | 20,523 | $55.0K | 0.00% | +6,451+45.8% | Added |
| Susquehanna International Group, LLP | 19,729 | $55.0K | 0.00% | +19,729 | New |
| Citadel Advisors LLC | 21,775 | $60.0K | 0.00% | −14,691−40.3% | Reduced |
| ACT Capital Management, LLC | 28,500 | $79.0K | 0.06% | 00.0% | Unchanged |
| Franklin Resources Inc | 43,700 | $121.0K | 0.00% | 00.0% | Unchanged |
| Dowling & Yahnke LLC | 47,455 | $131.0K | 0.01% | +7,000+17.3% | Added |
| Telemetry Investments, L.L.C. | 72,509 | $201.0K | 0.26% | −57,991−44.4% | Reduced |
| State Street Corp | 72,954 | $202.0K | 0.00% | 00.0% | Unchanged |
| Johnson & Johnson | 84,003 | $233.0K | 0.03% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 85,079 | $235.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 143,912 | $398.0K | 0.00% | −1,833−1.3% | Reduced |
| Two Sigma Investments, LP | 200,404 | $555.0K | 0.00% | −119,371−37.3% | Reduced |
| Renaissance Technologies LLC | 211,000 | $584.0K | 0.00% | −95,976−31.3% | Reduced |
| Boothbay Fund Management, LLC | 268,301 | $743.0K | 0.02% | 00.0% | Unchanged |
| Linden Advisors LP | 284,248 | $787.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 301,484 | $835.0K | 0.00% | +2,201+0.7% | Added |
| Two Sigma Advisers, LP | 332,000 | $920.0K | 0.00% | −35,800−9.7% | Reduced |
| NEA Management Company, LLC | 346,718 | $960.0K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 690,622 | $1.91M | 0.00% | −4,237−0.6% | Reduced |
| Ikarian Capital, LLC | 2,691,110 | $7.45M | 2.13% | 00.0% | Unchanged |
| Opaleye Management Inc. | 3,055,000 | $8.46M | 1.79% | +536,629+21.3% | Added |
| Altium Capital Management LP | 0 | $0 | 0.00% | −785,341−100.0% | Sold out |
| Psagot Value Holdings Ltd. / (Israel) | 0 | $0 | 0.00% | −143,591−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −139,477−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −85,993−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,938−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,755−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −445−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −223−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −131−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Psagot Investment House Ltd. | – | – | – | – | Not filed |